VKH
ARLZ

Virtu KCG Holdings’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Virtu KCG Holdings’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$127K Sell
94,398
-50,647
-35% -$73.2K ﹤0.01% 2349
2017
Q1 		$310K Buy
+145,045
New +$545K 0.01% 1916
2016
Q4 		– Sell
-57,241
Closed -$278K – 4191
2016
Q3 		$278K Buy
+57,241
New +$261K 0.01% 2000

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return

Virtu KCG Holdings's ARLZ Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Aralez Pharmaceuticals Inc. (ARLZ) stake by 35% in Q2 2017, selling an estimated $73.2K and leaving 94,398 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #2349.

Virtu KCG Holdings first reported a position in ARLZ in Q3 2016 and has held it in 3 quarters since. The position peaked at $310K in Q1 2017. 72 funds tracked by Wall St. Rank hold ARLZ as of Q2 2017.

  • Virtu KCG Holdings held 94,398 shares of Aralez Pharmaceuticals Inc. worth $127K as of Q2 2017.
  • Virtu KCG Holdings sold 50,647 Aralez Pharmaceuticals Inc. shares in Q2 2017, an estimated $73.2K.
  • Aralez Pharmaceuticals Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2349 holding.
  • Virtu KCG Holdings first reported a position in Aralez Pharmaceuticals Inc. in Q3 2016 and has held it in 3 quarters since.
  • Virtu KCG Holdings's Aralez Pharmaceuticals Inc. position peaked at $310K in Q1 2017.
  • 72 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.